Concepedia

Sofia Fernandes

SF

Statistics

Publications

6

Citations

188

H-Index

6

Active since

2011

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (United States)

Sofia Fernandes is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, clinical trials, and immunology.

ORCID

Top concepts

Publications per year

2011–2021

6

Publications

6

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

Emiliangelo Ratti, Kevin M. Bellew, P. Bettica et al. · Journal of Clinical Psychopharmacology · 2011 · 64 citations

, , +14

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia

Emiliangelo Ratti, David Carpenter, Stefano Zamuner et al. · SLEEP · 2013 · 46 citations · Full text

A Randomized Trial of Otilimab in Severe COVID-19 Pneumonia (OSCAR)

Jatin Patel, Albertus Beishuizen, Xavier Bocca Ruiz et al. · 2021 · 27 citations · Full text

, , +18

Day and night surgery: is there any influence in the patient postoperative period of urgent colorectal intervention?

Sofia Fernandes, Ana Franky Carvalho, Ana João Rodrigues et al. · International Journal of Colorectal Disease · 2016 · 20 citations · Full text

Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial

Georg Schett, Mario Berkowitz, Katherine Davy et al. · The Lancet Rheumatology · 2020 · 20 citations

, , +11

1–5 of 6